🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators propose a randomized phase II clinical trial of talazopar...
Status
Unknown
Location
Yonsei University College of Medicine
Start Date
2021-03
Trial ID
NCT04755868
Treatments Being Tested
A Single Arm Phase II Trial of BMN 673 for Inoperable, Advanced Endometrial...
Status
Withdrawn
Location
Royal Sussex County Hospital
Start Date
2014-10-01
Trial ID
NCT02127151
Treatments Being Tested
The purpose of this study is to find out whether talazoparib in combination...
Status
Recruiting
Location
City of Hope
Start Date
2026-05-04
Trial ID
NCT06844383
Treatments Being Tested
This is a single arm, open-label, phase I dose finding study, followed by a...
Status
Recruiting
Location
National University Hospital
Start Date
2021-03-01
Trial ID
NCT05035745
Treatments Being Tested
The goal of this clinical trial is to learn about the tolerability of telmi...
Status
Recruiting
Location
Dartmouth Health
Start Date
2024-04-22
Trial ID
NCT06168487
Treatments Being Tested
This is a two-part open label, non-randomized, Phase 2, study of ZEN003694 ...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2019-06-26
Trial ID
NCT03901469
Treatments Being Tested
The purpose of this study is to determine what the safest dose of talazopar...
Status
Terminated
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2019-07-11
Trial ID
NCT04019327
Treatments Being Tested
This purpose of this study is to test if talazoparib is safe and evaluate i...
Status
Withdrawn
Location
Stanford University
Start Date
2023-02-23
Trial ID
NCT04756765
Treatments Being Tested
The purpose of the study is to evaluate the safety and efficacy of talazopa...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2021-05-12
Trial ID
NCT04821622
Treatments Being Tested
This phase Ib trial is to find out the best dose, possible benefits and/or ...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-12-01
Trial ID
NCT04693468
Treatments Being Tested